ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1747

Native Americans Experience Profound Premature Mortality from Rheumatoid Arthritis

Parmita Das1, Snehin Rajkumar2, Eric Yen3 and Ram Singh4, 1University of California Los Angeles, Saint Johns, 2UCLA David Geffen School of Medicine, Irvine, CA, 3UCLA, Los Angeles, CA, 4UCLA David Geffen School of Medicine, Los Angeles, CA

Meeting: ACR Convergence 2024

Keywords: Demographics, Minority Health, Mortality, race/ethnicity, rheumatoid arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 17, 2024

Title: Abstracts: RA – Diagnosis, Manifestations, & Outcomes III: Best Day (RA Subpopulations)

Session Type: Abstract Session

Session Time: 3:00PM-4:30PM

Background/Purpose: Rheumatoid Arthritis (RA) is a chronic debilitating disease affecting up to 1% of the US population and has variable outcomes by race/ethnicity. We analyzed RA mortality by race/ethnicity to determine if racial/ethnic minority groups experience higher premature mortality.

Methods: We used the Centers for Disease Control and Prevention’s national mortality database to obtain death counts for RA in the United States for each year from 1999 to 2020 by race/ethnicity [non-Hispanic (NH) American Indian or Alaska Native (Native American), NH-Asian/Pacific Islander (A/PI), NH-black or African American (black), NH-white, and Hispanic or Latino (Hispanic)], age [≤44, 45-64 and ≥65 years], sex, and calendar year periods (1999-2009 and 2010-2020).  We calculated age-standardized mortality rates (ASMR) with 95% confidence interval (CI) by each of these variables. We analyzed trends in RA mortality by race/ethnicity and age over the 22-year period using Joinpoint regression trend analysis. We performed multiple regression analysis by race/ethnicity adjusting for age, sex, and calendar year periods, and then included interactions in the model to identify any effect modification among these variables. 

Results: There were 200,228 RA deaths from 1999 through 2020. The ASMR was the highest in Native Americans (5.14 per 100,000 persons, 95% CI, 4.91-5.38), followed by non-Hispanic (NH) whites (2.87, 95% CI, 2.86-2.88), NH-blacks (2.25, 95% CI, 2.21-2.29), Hispanics (2.15, 95% CI, 2.11-2.19), and NH-A/PIs (1.26, 95% CI, 1.21-1.30). Notably, the RA-ASMR was 10.8-fold higher at age ≤44, 3-fold at ages 45-64, and only 1.6-fold higher at ≥65 in Native American than in NH-whites. NH-blacks also had higher ASMR at ≤44 years but not at older ages relative to NH-whites. By age 65, significantly higher proportions of Native Americans died of RA relative to NH-whites (36% vs 14%, p< 0.01). Trend analysis showed that at age < 65 years, RA-ASMR significantly decreased from 1999 through 2018 in all race/ethnicities except in Native Americans. Multiple regression analysis revealed that the adjusted odds of death from RA was significantly higher (1.67, 95% CI 1.59-1.74, p< 0.001) in Native Americans but not in other race/ethnic groups relative to NH-whites. Significant interactions were detected for race/ethnicity–age and race/ethnicity–sex. Stratified analysis showed that the odds of RA death were significantly higher for Native Americans relative to NH-whites in both younger and older males and females; it was most profound in younger (< 65) females (odds ratio, 2.65, 95% CI 2.42-2.90) followed by younger males (1.56, 95% CI 1.33-1.83), older females, and older males.

Conclusion: RA mortality differs by race/ethnicity, with the highest premature mortality in Native Americans. Further investigations to understand the causes of these differences in premature mortality may help guide research and resource allocation to improve patient outcomes in the highest risk groups.


Disclosures: P. Das: None; S. Rajkumar: None; E. Yen: None; R. Singh: None.

To cite this abstract in AMA style:

Das P, Rajkumar S, Yen E, Singh R. Native Americans Experience Profound Premature Mortality from Rheumatoid Arthritis [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/native-americans-experience-profound-premature-mortality-from-rheumatoid-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/native-americans-experience-profound-premature-mortality-from-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology